-
Lilly to appeal after CHMP rejects Alzheimer's drug Kisunla
31 Mar 2025 11:44 GMT
… (ARIA) with the drug, like brain bleeding and … medicines, Averoa's Xoanacyl (ferric citrate coordination complex) for the treatment … formulation of blockbuster cancer drug Opdivo (nivolumab).
Meanwhile, … of the safety of Orexigen's weight-loss …
-
EMA Recommends Five New Medicines for Approval
28 Mar 2025 21:17 GMT
… Calquence (acalabrutinib), Flucelvax (influenza vaccine—surface antigen, inactivated, prepared … CHMP recommended a new pharmaceutical form as well as … seed), an herbal medicine for treatment of moderate-to- … a review of Orexigen Therapeutics Ireland’s Mysimba …
-
Anti-Obesity Drugs Market to Expand from USD 4.6 Billion in 2023 to USD 39.3 Billion by 2033
06 Feb 2025 07:52 GMT
… trial data collection.
•Personalized Treatments: AI customizes obesity treatments … biotechnology … medications.
The presence of major pharmaceutical companies ensures easy access to innovative drugs …
•Orexigen Therapeutics, Inc.
•Rhythm Pharmaceuticals, …
-
Determining the Correlation Between Obesity Management Drug Dispensed Prescriptions and Online Search Behavior
31 Jan 2025 04:39 GMT
… treatments of a healthy diet and exercise, the pharmaceutical … clinical trials have been demonstrating that this drug class … :
FDA-approved OMDs (naltrexone and bupropion [Contrave; Orexigen Therapeutics … shift in obesity medication patterns, with semaglutide …
-
Increase in online searches for obesity drugs correlates with rise in prescriptions
29 Jan 2025 21:15 GMT
… for FDA-approved medications for obesity and GLP-1-based drugs for diabetes … for naltrexone/bupropion (Contrave, Orexigen Therapeutics) from July 2022 through … prescribed off-label for obesity treatment,” the researchers wrote. “We considered …
-
Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors
18 Nov 2024 21:05 GMT
… Turner is a seasoned biotechnology executive with 25 years … Therapeutics, Atara Biotherapeutics, Orexigen Therapeutics, and Conor Medsystems … Barbara. About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a … of the clinical trials and other development …
-
Updated advice to minimise risks of interaction between weight loss medicine Mysimba and opioids
15 Nov 2024 16:03 GMT
… ensure clearance of opioid medication before starting treatment with Mysimba.
Patients must … the company that markets Mysimba, Orexigen Therapeutics Ireland Limited, to submit … a group of experts including doctors specialised in anaesthesiology, obesity and …
-
FDA Commissioner Shills for New Diet Drugs
17 Oct 2024 18:57 GMT
… of us consult with the pharmaceutical industry, which I think … Califf presided over a discredited drug trial of the blood thinner Xarelto … to an experimental cancer treatment at Duke occurred while … medical journals and a great university." This is FDA …
-
Currax, maker of weight loss drug Contrave, constructs campaign to educate on 'food noise'
24 Sep 2024 19:06 GMT
… -1 agonists and other obesity medications.
Currax Pharmaceuticals, the maker of one … originally owned by Orexigen Therapeutics, under which it earned FDA approval in … of the team-up, and Orexigen filed for bankruptcy two years …
-
EMA advises about risks of using weight loss medicine Mysimba with opioids
26 Jul 2024 14:04 GMT
… treatment with opioid medicines. This is in addition to the existing contraindications stating … of anaesthesia and pain treatment.
Inform your doctor that you are using … the company that markets Mysimba, Orexigen Therapeutics Ireland Limited, to submit …